Osimertinib Dose Escalation Induces Regression of Progressive EGFR T790M–Mutant Leptomeningeal Lung Adenocarcinoma

Christine Cordova(Cleveland Clinic), Matija Snuderl, Douglas Kondziolka(Neurological Surgery), Joshua S. Silverman(NYU Langone Health), Timothy M. Shepherd(NYU Langone Health), Abraham Chachoua(New York University), Rajan Jain(NYU Langone Health)
Journal of Thoracic Oncology
October 27, 2017
Cited by 22


Related Papers